Has Johannes Brechtken, MD received payments from drug or device companies?

Yes. Drug and device makers reported $99,544 in general payments to Johannes Brechtken, MD across 386 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Johannes Brechtken, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Johannes Brechtken, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Johannes Brechtken, MD

Cardiovascular Disease · Saint Paul, MNNPI 1427088392

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Boston Scientific at 47.1% of the total. Among cardiovascular disease clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$99,544in general payments, 2019–2025

Across 386 payments — averaging $257.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$47K
Edwards Lifesciences$31K
Medtronic$16K
Abbott$3K
Opsens Inc.$2K
Abiomed$634
plus $348 from 3 others

$29,496in research payments, 2019–2025

Across 16 payments — averaging $1843.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$29K

What the payments were for

Consulting fees$52,53153%
Speaking & faculty fees$8,2408%
Travel & lodging$23,03923%
Food & beverage$15,58816%
Education$1210%
Entertainment$250%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	84	$46,839
Edwards Lifesciences	120	$30,942
Medtronic(2 entities)	142	$15,907
Abbott	16	$2,707
Opsens Inc.	4	$2,168
Abiomed	4	$634
Shockwave Medical, Inc	1	$183
Chiesi USA, Inc.	14	$121
Cardiva Medical, Inc.	1	$43

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CoreValve Evolut$10,389
Edwards SAPIEN 3 Transcatheter Heart Valve$9,934
GENERAL BALLOONS$7,500
GENERAL - THERAPIES$6,523
GENERAL VASCULAR ACCESS$4,913
GENERAL - STRUCTURAL HEART$4,000
WATCHMAN Access System$3,736
AVVIGO Guidance System$3,191
GENERAL CATHETER$2,500
COREVALVE EVOLUT R$2,432
VersaCross Access Solution$2,220
Mitra Clip system$2,202
OptoWire$2,109
OptoMonitor$2,109
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$1,893
SAPIEN 3 Ultra RESILIA$774
Impella$634
AVVIGO$600
ROTAPRO$600
GENERAL KIDNEY STONE DISEASE$384

How this compares

$99,544 in reported general payments places this provider in the 90th percentile of 451 cardiovascular disease providers in Minnesota.

See all cardiovascular disease providers in Minnesota →

Medicare billing

Part B allowed, 2024

$117,682

Medicare patients

1,915

Services billed

2,658

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	33	$48,115
Rosuvastatin Calcium	78	$1,393
ClopidogrelClopidogrel Bisulfate	74	$1,247
Metoprolol Succinate	51	$687
Atorvastatin Calcium	32	$397
Amlodipine Besylate	78	$368
Ezetimibe	22	$365
Losartan Potassium	20	$290
Carvedilol	18	$212
Lisinopril	23	$209
Nitroglycerin	12	$167
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide	14	$112
Hydrochlorothiazide	13	$45

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Saint Paul

Thomas BiggsSaint Paul$244K
Pierce VatterottSaint Paul$146K
Spencer KuboSaint Paul$134K
Nishtha SodhiSaint Paul$50K
Jeffrey ChambersMinneapolis$3.2M
Srijoy MahapatraRochester$1.2M
Markus MeyerMinneapolis$786K
Robert SchwartzMinneapolis$502K
Robert VantasselMinneapolis$493K
Charanjit RihalRochester$478K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →